Collegium Pharmaceutical (COLL) EBT Growth (1y) (2015 - 2026)
Collegium Pharmaceutical (COLL) EBT Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Collegium Pharmaceutical | 894.62 Mn | 745.30 Mn | 110.29 Mn | -179.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -179.48% |
| Mar 31, 2026 | 500.26% |
| Dec 31, 2025 | 68.14% |
| Sep 30, 2025 | 178.79% |
| Jun 30, 2025 | -41.49% |
| Mar 31, 2025 | -91.48% |
| Dec 31, 2024 | -63.03% |
| Sep 30, 2024 | -45.87% |
| Jun 30, 2024 | 63.49% |
| Mar 31, 2024 | 308.59% |
| Dec 31, 2023 | 699.54% |
| Sep 30, 2023 | 1,909.99% |
| Jun 30, 2023 | 367.79% |
| Mar 31, 2023 | -10.83% |
| Dec 31, 2022 | 79.96% |
| Sep 30, 2022 | -84.15% |
| Jun 30, 2022 | -160.47% |
| Mar 31, 2022 | -202.38% |
| Dec 31, 2021 | -635.33% |
| Sep 30, 2021 | -21.87% |